§ 56.113. Suspension or termination of IRB approval of research.
68 words·~1 min read·
/us/cfr/t21/s§ 56.113·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
An IRB shall have authority to suspend or terminate approval of research that is not being conducted in accordance with the IRB's requirements or that has been associated with unexpected serious harm to subjects. Any suspension or termination of approval shall include a statement of the reasons for the IRB's action and shall be reported promptly to the investigator, appropriate institutional officials, and the Food and Drug Administration.
Connections3 cite this
Cited by 3 sections
Citation graph
cites case law
§ 56.113
Suspension or termination of IRB approval of research.
Fed. Reg.×3
Cites 0Cited by 3 across 1 source